Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus receives final approval from the US FDA for Sildenafil for oral suspension
Sildenafil for oral suspension is used to treat high blood pressure in the lungs (pulmonary hypertension)
Entod Pharma’s eye drop might replace reading glasses soon
Entod Pharma is in the final stages of developing the eye drop known as "PresVu"
Pharma industry’s deal value decreases by 74.8 per cent in September 2022
Venture capital investments decreased by 45.8 per cent in September 2022, compared to September 2021
Lupin appoints Dr Shahin Fesharaki as Global Chief Scientific Officer
Dr Fesharaki will be responsible for Lupin’s global research and development efforts across branded, generics and specialty…
Pfizer COVID vaccine clears Japan panel for use with young children
Japan in January expanded use of the vaccine to those as young as five years old
Maiden Pharma trying to find out about cough syrup-linked deaths in Gambia
Tedros Adhanom Ghebreyesus, Director-General, WHO, last week told reporters the UN agency was investigating 66 deaths from acute…
Re-setting the pharma procurement value chain
Procurement experts highlight how increasing the resilience and agility of supply chains, with technology as a pivot, is crucial…
Antibacterial Resistance Leadership Group (ARLG) begins clinical trial of phage therapy for cystic…
The trial is evaluating whether the bacteriophage, or “phage,” therapy is safe and able to reduce the amount of bacteria in the…
Zydus receives final US FDA approval for Brivaracetam tablets
Brivaracetam is indicated for the treatment of partial-onset seizures in patients four years of age and older
In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults
With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…